title: Meeting report: risk assessment of tamiflu use under pandemic conditions.
abstract: On 3 October 2007, 40 participants with diverse expertise attended the workshop Tamiflu and the Environment: Implications of Use under Pandemic Conditions to assess the potential human health impact and environmental hazards associated with use of Tamiflu during an influenza pandemic. Based on the identification and risk-ranking of knowledge gaps, the consensus was that oseltamivir ethylester-phosphate (OE-P) and oseltamivir carboxylate (OC) were unlikely to pose an ecotoxicologic hazard to freshwater organisms. OC in river water might hasten the generation of OC-resistance in wildfowl, but this possibility seems less likely than the potential disruption that could be posed by OC and other pharmaceuticals to the operation of sewage treatment plants. The work-group members agreed on the following research priorities: a) available data on the ecotoxicology of OE-P and OC should be published; b) risk should be assessed for OC-contaminated river water generating OC-resistant viruses in wildfowl; c) sewage treatment plant functioning due to microbial inhibition by neuraminidase inhibitors and other antimicrobials used during a pandemic should be investigated; and d) realistic worst-case exposure scenarios should be developed. Additional modeling would be useful to identify localized areas within river catchments that might be prone to high pharmaceutical concentrations in sewage treatment plant effluent. Ongoing seasonal use of Tamiflu in Japan offers opportunities for researchers to assess how much OC enters and persists in the aquatic environment.
authors.affiliation: Centre for Ecology & Hydrology, Oxford, United Kingdom. acsi@ceh.ac.uk
authors.forename: Andrew C
authors.initials: AC
authors.lastname: Singer
authors.forename: Bruce M
authors.initials: BM
authors.lastname: Howard
authors.forename: Andrew C
authors.initials: AC
authors.lastname: Johnson
authors.forename: Chris J
authors.initials: CJ
authors.lastname: Knowles
authors.forename: Simon
authors.initials: S
authors.lastname: Jackman
authors.forename: Cesare
authors.initials: C
authors.lastname: Accinelli
authors.forename: Anna Barra
authors.initials: AB
authors.lastname: Caracciolo
authors.forename: Ian
authors.initials: I
authors.lastname: Bernard
authors.forename: Stephen
authors.initials: S
authors.lastname: Bird
authors.forename: Tatiana
authors.initials: T
authors.lastname: Boucard
authors.forename: Alistair
authors.initials: A
authors.lastname: Boxall
authors.forename: Jayne V
authors.initials: JV
authors.lastname: Brian
authors.forename: Elise
authors.initials: E
authors.lastname: Cartmell
authors.forename: Chris
authors.initials: C
authors.lastname: Chubb
authors.forename: John
authors.initials: J
authors.lastname: Churchley
authors.forename: Sandra
authors.initials: S
authors.lastname: Costigan
authors.forename: Mark
authors.initials: M
authors.lastname: Crane
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Dempsey
authors.forename: Bob
authors.initials: B
authors.lastname: Dorrington
authors.forename: Brian
authors.initials: B
authors.lastname: Ellor
authors.forename: Jerker
authors.initials: J
authors.lastname: Fick
authors.forename: John
authors.initials: J
authors.lastname: Holmes
authors.forename: Tom
authors.initials: T
authors.lastname: Hutchinson
authors.forename: Franz
authors.initials: F
authors.lastname: Karcher
authors.forename: Samuel L
authors.initials: SL
authors.lastname: Kelleher
authors.forename: Peter
authors.initials: P
authors.lastname: Marsden
authors.forename: Gerald
authors.initials: G
authors.lastname: Noone
authors.forename: Miles A
authors.initials: MA
authors.lastname: Nunn
authors.forename: John
authors.initials: J
authors.lastname: Oxford
authors.forename: Tony
authors.initials: T
authors.lastname: Rachwal
authors.forename: Noel
authors.initials: N
authors.lastname: Roberts
authors.forename: Mike
authors.initials: M
authors.lastname: Roberts
authors.forename: Maria Ludovica
authors.initials: ML
authors.lastname: Saccà
authors.forename: Matthew
authors.initials: M
authors.lastname: Sanders
authors.forename: Jürg Oliver
authors.initials: JO
authors.lastname: Straub
authors.forename: Adrian
authors.initials: A
authors.lastname: Terry
authors.forename: Dean
authors.initials: D
authors.lastname: Thomas
authors.forename: Stephen
authors.initials: S
authors.lastname: Toovey
authors.forename: Rodney
authors.initials: R
authors.lastname: Townsend
authors.forename: Nikolaos
authors.initials: N
authors.lastname: Voulvoulis
authors.forename: Chris
authors.initials: C
authors.lastname: Watts
mesh_terms: D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy*; D053139:Oseltamivir / Q000627:therapeutic use*; D018570:Risk Assessment
chemical_list: D053139:Oseltamivir